160 related articles for article (PubMed ID: 38459456)
1. Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells.
Mathur S; Srivastava P; Srivastava A; Rai NK; Abbas S; Kumar A; Tiwari M; Sharma LK
BMC Cancer; 2024 Mar; 24(1):323. PubMed ID: 38459456
[TBL] [Abstract][Full Text] [Related]
2. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells.
Koch DT; Yu H; Beirith I; Schirren M; Drefs M; Liu Y; Knoblauch M; Koliogiannis D; Sheng W; De Toni EN; Bazhin AV; Renz BW; Guba MO; Werner J; Ilmer M
J Transl Med; 2023 Dec; 21(1):876. PubMed ID: 38041179
[TBL] [Abstract][Full Text] [Related]
3. Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers.
Dong Z; Abbas MN; Kausar S; Yang J; Li L; Tan L; Cui H
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336613
[TBL] [Abstract][Full Text] [Related]
4. COX19 Is a New Target of MACC1 and Promotes Colorectal Cancer Progression by Regulating Copper Transport in Mitochondria.
Gao S; Zhang H; Zhang X; Wang J; Bai W; Jiang B
J Nutr; 2024 Feb; 154(2):381-394. PubMed ID: 38141772
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
Wang G; Wang Q; Huang Q; Chen Y; Sun X; He L; Zhan L; Guo X; Yin C; Fang Y; He X; Xing J
Int J Cancer; 2019 May; 144(10):2516-2528. PubMed ID: 30415472
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of mitochondrial complex I and oxidative stress based on metastatic potential of colorectal cancer cells.
Rai NK; Mathur S; Singh SK; Tiwari M; Singh VK; Haque R; Tiwari S; Kumar Sharma L
Oncol Lett; 2020 Dec; 20(6):313. PubMed ID: 33093922
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion combined with tigecycline inhibits lung cancer cell proliferation by inducing mitochondrial dysfunction.
Yan J; Xie Y; Wang F; Chen Y; Zhang J; Dou Z; Gan L; Li H; Si J; Sun C; Di C; Zhang H
Life Sci; 2020 Dec; 263():118586. PubMed ID: 33065148
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage.
Xiong Y; Liu W; Huang Q; Wang J; Wang Y; Li H; Fu X
Sci Rep; 2018 Aug; 8(1):11747. PubMed ID: 30082885
[TBL] [Abstract][Full Text] [Related]
9. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
10. TOMM20 as a potential therapeutic target of colorectal cancer.
Park SH; Lee AR; Choi K; Joung S; Yoon JB; Kim S
BMB Rep; 2019 Dec; 52(12):712-717. PubMed ID: 31818360
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer cells through antibiotics-induced mitochondrial dysfunction requires autophagy inhibition.
Esner M; Graifer D; Lleonart ME; Lyakhovich A
Cancer Lett; 2017 Jan; 384():60-69. PubMed ID: 27693455
[TBL] [Abstract][Full Text] [Related]
12. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
13. Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells.
Liu Q; Zhang L; Zou Y; Tao Y; Wang B; Li B; Liu R; Wang B; Ding L; Cui Q; Lin J; Mao B; Xiong W; Yu M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293209
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity in colorectal cancer induced by hinokiflavone.
Zhou J; Zhao R; Ye T; Yang S; Li Y; Yang F; Wang G; Xie Y; Li Q
J Gastroenterol Hepatol; 2019 Sep; 34(9):1571-1580. PubMed ID: 30575109
[TBL] [Abstract][Full Text] [Related]
16. Penfluridol triggers mitochondrial-mediated apoptosis and suppresses glycolysis in colorectal cancer cells through down-regulating hexokinase-2.
Wang NN; Zhang PZ; Zhang J; Wang HN; Li L; Ren F; Dai PF; Li H; Lv XF
Anat Rec (Hoboken); 2021 Mar; 304(3):520-530. PubMed ID: 32470200
[TBL] [Abstract][Full Text] [Related]
17. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.
Liu W; Chen S; Xie W; Wang Q; Luo Q; Huang M; Gu M; Lan P; Chen D
Cell Mol Biol Lett; 2023 Oct; 28(1):80. PubMed ID: 37828426
[TBL] [Abstract][Full Text] [Related]
18. MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth.
Liu Y; Jin M; Wang Y; Zhu J; Tan R; Zhao J; Ji X; Jin C; Jia Y; Ren T; Xing J
Signal Transduct Target Ther; 2020 May; 5(1):59. PubMed ID: 32371956
[TBL] [Abstract][Full Text] [Related]
19. Novel benzoate-lipophilic cations selectively induce cell death in human colorectal cancer cell lines.
Jara JA; Rojas D; Castro-Castillo V; Fuentes-Retamal S; Sandoval-Acuña C; Parra E; Pavani M; Maya JD; Ferreira J; Catalán M
Toxicol In Vitro; 2020 Jun; 65():104814. PubMed ID: 32112803
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity.
Wang Y; Xie F; Chen D; Wang L
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):890-897. PubMed ID: 31209921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
